Enhancement of cyclosporine aqueous solubility using α- And hydroxypropyl β-cyclodextrin mixtures

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 59, Issue 3-4, 2007, Pages 245-250

  Malaekeh Nikouei, B ^a   Nassirli, H ^a   Davies, N ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aqueous solubility; Cyclodextrin; Cyclosporin A; Phase solubility

Indexed keywords

EID: 36049038899     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-007-9321-4     Document Type: Article

References (27)

1. Allison, A.C.: Immunosuppressive drugs: The first 50 years and a glance forward. Immunopharmacology 47, 63-83 (2000)
2. Kawabata, T.T., Munson, A.E.: Immunopharmacology. In: Brody, T.M., Larner, J., Minneman, K.P. (eds.) Human pharmacology, molecular to clinical, 3rd edn. pp. 599-637. Mosby, USA (1998)
3. Lake, D.F., Akporiaye, E.T., Hersh, E.M.: Immunopharmacology. In: Katzung, B.G. (ed.) Basic & clinical pharmacology, 8th edn. pp. 959-986. The McGraw-Hill Companies, USA (2001)
4. Ptachcinski, R.J., Venkataramanan, R., Burckart G.J.: Clinical pharmacokinetics of cyclosporine. Clin. Pharmacokinet. 11(2), 107-132 (1986)
5. Lee, E., Choi, H., Lee, S., Kim, C.: Bioavailability of cyclosporine A dispersed in sodium lauryl sulfate dextrin based Solid microspheresInt. J. Pharm. 218, 125-131 (2001)
6. Guo, J., Chen, Y., Ping, Q.: 6) Pharmacokinetic behavior of cyclosporine A in rabbits by oral administration of lecithin and Sandimmun Neoral. Int. J. Pharm. 216, 17-21 (2001)
7. Al-Meshal, M.A., Khadir, S.H., Bayomi, M.A., Al-Angary, A.A.: Oral administration of liposomes containing cyclosporine: A pharmacokinetic studyInt. J. Pharm. 168, 163-168 (1998)
8. Gelderblom, H., Verweij, J., Nooter, K., Sparreboom, A.: 8) Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590-1598 (2001)
9. Loftsson, T., O'Fee, R.: Cyclodextrins in solid dosage forms. Business Briefing: Pharmatech. 176-180 (2003)
10. Davis, M.E., Brewster, M.E.:Cyclodextrin-based pharmaceutics: Past, present and future. Nature Rev. 3, 1023-1035 (2004)
11. Loftsson, T., Masson, M.: Cyclodextrins in topical drug formulations: Theory and practice. Int. J. Pharm. 225, 15-30 (2001)
12. Martin Del Valle, E.M.: Cyclodextrins and their uses: A review. Process Biochem. 39, 1033-1046 (2004)
13. Filipovic-Grcic, J., Voinovich, D., Moneghini, M., Becirevic-Lacan, M., Magarotto, L., Jalsenjak, I.: Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-β-cyclodextrin inclusion complex. Eur. J. Pharm. Biopharm. 9, 373-379 (2000)
14. Filipovic-Grcic, J., Becirevic-Lacan, M., Skalko, N., Jalsenjak, I.: Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. Int. J. Pharm. 135, 183-190 (1996)
15. Loftsson, T., Matthiasson, K., Masson, M.: The effect of organic salts on cyclodextrin solubilization of drugs. Int. J. Pharm. 262, 101-107 (2003)
16. Ran, Y., Zhao, L., Xu, Q., Yalkowsky, S.H.: 16) Solubilization of cyclosporine A. AAPS PharmSciTech 20(1), article 2 (2001)
17. Loftsson, T., Magnudottir, A., Masson, M., Sigurjonsdottir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91(11), 2307-2316 (2002)
18. Fromming, K., Szejtli, J.: CDs in Pharmacy. Kluwer Academic Publishers, Netherlands (1994) pp. 1-32
19. Suzuki, M., Tasutsui, M., Ohamori, H.: NMR study of the self-assembly of an azo dye-cyclomaltooctanose (γ-cyclodextrin) complex. Carbohyd. Res. 264, 233-230 (1994)
20. Fukaya, H., Iimura, A., Hoshiko, K., Fuyumuro, T., Noji, S., Nabeshima, T.: A cyclosporin A/maltosyl-α-cyclodextrin complex for inhalation therapy of asthma. Eur. Respir. J. 22(2), 213-219 (2003)
21. Zhang, A., Liu, W., Wang L., Wen Y.: Characterization of inclusion complexation between fenoxaprop-p-ethyl and cyclodextrin. J. Agr. Food Chem. 53(18), 7193-7197 (2005)
22. Liu, L., Zhu, S.: 22) Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. J. Pharm. Biomed. Anal. 40(1), 122-127 (2006)
23. Anselmi, C., Centini, M., Ricci, M., Buonocore, A., Granata, P., Tsuno, T., Facino, R.M.: 23) Analytical characterization of a ferulic acid/γ-cyclodextrin inclusion complex. J. Pharm. Biomed. Anal. 40(4), 875-881 (2006)
24. Zerrouk, N., Gine's Dorado, J.M., Arnaud, P., Chemtob, C.: 24) Physical characteristics of inclusion compounds of 5-ASA in α and β cyclodextrins. Int. J. Pharm. 171, 19-29 (1998)
25. Calabrò, M.L., Tommasini, S., Donato, P., Raneri, D., Stancanelli, R., Ficarra, P., Costa, C., Catania, S., Rustichelli, C., Gamberini, G.: 25) Effects of α- and β-cyclodextrin complexation on the physicochemical properties and antioxidant activity of some 3-hydroxyflavones. J. Pharm. Biomed. Anal. 35, 365-377 (2004)
26. Luciana, M.A, Fraceto, L.F., Santana, M.H.A., Pertinhez, T.A., Junior, S.O., de Paula, E.: 26) Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes. J. Pharm. Biomed. Anal. 39(5), 956-963 (2005)
27. Li, N., Zhang, Y., Wu, Y., Xiong, X., Zhang, Y.: 27) Inclusion complex of trimethoprim with β-cyclodextrin. J. Pharm. Biomed. Anal. 39(3-4), 824-829 (2005)